Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$19.47 - $28.49 $12,285 - $17,977
631 Added 6.22%
10,770 $244,000
Q4 2022

Feb 13, 2023

SELL
$18.08 - $30.0 $29,398 - $48,780
-1,626 Reduced 13.82%
10,139 $238,000
Q3 2022

Nov 03, 2022

SELL
$22.51 - $34.32 $9,319 - $14,208
-414 Reduced 3.4%
11,765 $307,000
Q2 2022

Aug 16, 2022

BUY
$16.0 - $45.99 $42,096 - $120,999
2,631 Added 27.56%
12,179 $267,000
Q1 2022

May 16, 2022

BUY
$33.17 - $46.98 $63,653 - $90,154
1,919 Added 25.15%
9,548 $428,000
Q4 2021

Feb 09, 2022

BUY
$39.06 - $67.58 $297,988 - $515,567
7,629 New
7,629 $327,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $726M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.